Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Inna, Ospovat"'
Autor:
Nanette Freedman, Mattias Sandström, Jonathan Kuten, Natan Shtraus, Inna Ospovat, Albert Schlocker, Einat Even-Sapir
Publikováno v:
EJNMMI Physics, Vol 7, Iss 1, Pp 1-15 (2020)
Abstract Purpose Over recent years, peptide receptor radiotherapy (PRRT) has been recognized as an effective treatment for patients with metastatic neuroendocrine tumors (NETs). Personalized dosimetry can contribute to improve the outcome of peptide
Externí odkaz:
https://doaj.org/article/cd307c1f09cd4567a520d61080c066ec
Autor:
Anton Warshavsky, Ariel Holan, Nidal Muhanna, Yael Oestraicher, Yuval Nachalon, Liyona Kampel, Narin Nard‐Carmel, Hen Chaushu, Udi Shapira, Omer Ungar, Orit Gutfeld, Inna Ospovat, Yasmin Natan Oz, Einat Even‐Sapir, Gilad Horowitz
Publikováno v:
HeadneckREFRENCES. 45(1)
Larynx preservation protocols (LPP) for glottic primary squamous cell carcinoma has gained popularity worldwide. Direct laryngoscopy (DL) with biopsy is mandated when recurrence is suspected. The efficacy of 18Fluoro-deoxy-glucose positron emission c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::144555bf7b0257122d012ec5708cc256
https://pubmed.ncbi.nlm.nih.gov/36301004
https://pubmed.ncbi.nlm.nih.gov/36301004
Autor:
Mirjam E. Bosman, Christoph Losert, Bianca A.W. Hoeben, Stéphane Supiot, Soraya Mico Milla, Montserrat Pazos, Michael H. Albert, Marc Bierings, Geert O. Janssens, Jacob Engellau, Candan Demiröz Abakay, Inna Ospovat, Tom Boterberg, Farkhad Manapov, Gregor Kos, Enrica Seravalli
Publikováno v:
Scientia
Pediatric; Radiotherapy; Stem cell transplantation Pediatria; Radioteràpia; Trasplantament de cèl·lules mare Pediatría; Radioterapia; Trasplante de células madre Background and purpose To reduce relapse risk, Total Body Irradiation (TBI) is part
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d517c3c1129d9deaf17c94ad9b0407e
https://doi.org/10.1016/j.radonc.2020.10.032
https://doi.org/10.1016/j.radonc.2020.10.032
Autor:
Alla Berlin, Leora Brazg Ferro, Ester Osher, Orit Gutfeld, Inbal Golomb, Inna Ospovat, Viacheslav Soyfer, Ido Wolf, Shira Peleg Hasson
Publikováno v:
Oncology. 99:373-379
Introduction: Extrapulmonary small-cell cancer (EPSCC) is a relatively rare malignancy. The management of EPSCC is usually extrapolated from small-cell lung cancer (SCLC). In spite of the morphological similarity of the 2 malignancies, there are many
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3be26017962c0af75d8b32df5e25157
https://doi.org/10.1159/000514520
https://doi.org/10.1159/000514520
Autor:
Aron Popovtzer, Yael Bar, Orit Gutfeld, Assaf Moore, Noa Gordon, Corinne Maurice-Dror, Salem Billan, Yasmin Korzets, Hadar Goldvaser, Michal Sarfaty, Inna Ospovat
Publikováno v:
Head & Neck. 42:599-607
BACKGROUND Salivary gland cancers (SGCs) are rare. The approach to metastatic patients is histology-dependent. There is little evidence on whether next-generation sequencing (NGS) findings translate to tumor control in SGCs. METHODS We analyzed all p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af8cfba960aa2bc07ceb89f21ac8f2fe
https://doi.org/10.1002/hed.26026
https://doi.org/10.1002/hed.26026
Autor:
Shira Peleg Hasson, Alex Barenboim, Hagit Tulchinsky, Ido Wolf, Inna Ospovat, Ravit Geva, Sharon Pelles
Publikováno v:
Clinical Oncology and Research. :1-6
Introduction: Rectal cancer is a common and lethal disease, with approximately 44,180 new cases of diagnosed annually in the United States and a five-year survival of 67% [1, 2]. The interval from diagnosis to chemoradiation treatment, or waiting tim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6f45e590559aae4064a8963a8f07f0a7
https://doi.org/10.31487/j.cor.2020.03.06
https://doi.org/10.31487/j.cor.2020.03.06
Autor:
Odelia Amit, Yael Bar-On, Dina Tshernichovsy, Ron Ram, Yakir Moshe, Inna Ospovat, Ofrat Beyar-Katz, Irit Avivi
Publikováno v:
Blood. 138:2860-2860
Introduction - primary refractory AML is associated with a dismal prognosis. Only 30% of patients will respond to salvage chemotherapy and continue to allogeneic hematopoietic cell transplantation (HCT) with a 10-20% long- term overall survival. Foll
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::14d5b756bd3d2424dc1097daf0e6590c
https://doi.org/10.1182/blood-2021-152699
https://doi.org/10.1182/blood-2021-152699
Autor:
Orit Gutfeld, Salem Billan, Assaf Moore, Aron Popovitzer, Inna Ospovat, Yael Bar, Corinne Maurice Dror, Noa Gordon
Publikováno v:
Journal of Clinical Oncology. 37:e17582-e17582
e17582 Background: Salivary gland cancers (SGCs) are rare tumors. The approach to recurrent or metastatic patients is histology dependent, as the clinical course is highly variable. Response rates to chemotherapy are modest and no second-line therapi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cd599aabcde33923dad2fa9622d7a587
https://doi.org/10.1200/jco.2019.37.15_suppl.e17582
https://doi.org/10.1200/jco.2019.37.15_suppl.e17582
Autor:
Ayala Hubert, Inna Ospovat, Tal Grenader, Nava Siegelmann-Danieli, Tamar Hamburger, Tamar Peretz
Publikováno v:
Tumori Journal. 95:683-686
Background Metastatic breast cancer has a substantial mortality burden on women worldwide. Presented herein is our experience with the combination of mitomycin-C and vinblastine in heavily pretreated breast cancer patients. Methods Candidates were wo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9676f220cb86a26e4261ab397f8cacb9
https://doi.org/10.1177/030089160909500607
https://doi.org/10.1177/030089160909500607
Autor:
Tamar Sella, Amir Sonnenblick, Ofer Merimsky, Daniela Katz, Inna Ospovat, Nili Peylan-Ramu, Feras Eleyan, Tamar Peretz
Publikováno v:
Molecular and clinical oncology. 3(4)
A limited number of chemotherapeutic agents have been found to be active against advanced soft-tissue sarcomas (STSs), particularly sarcomas that have progressed following doxorubicin treatment. The aim of this retrospective study was to determine th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bac3cdc97ebd4f5537329b605c7712e
https://pubmed.ncbi.nlm.nih.gov/26171190
https://pubmed.ncbi.nlm.nih.gov/26171190